Correlation Between Candel Therapeutics and ABPRO P

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and ABPRO P at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and ABPRO P into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and ABPRO P, you can compare the effects of market volatilities on Candel Therapeutics and ABPRO P and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of ABPRO P. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and ABPRO P.

Diversification Opportunities for Candel Therapeutics and ABPRO P

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Candel and ABPRO is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and ABPRO P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABPRO P and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with ABPRO P. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABPRO P has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and ABPRO P go up and down completely randomly.

Pair Corralation between Candel Therapeutics and ABPRO P

Given the investment horizon of 90 days Candel Therapeutics is expected to generate 0.98 times more return on investment than ABPRO P. However, Candel Therapeutics is 1.02 times less risky than ABPRO P. It trades about 0.2 of its potential returns per unit of risk. ABPRO P is currently generating about -0.44 per unit of risk. If you would invest  465.00  in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of  310.00  from holding Candel Therapeutics or generate 66.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Candel Therapeutics  vs.  ABPRO P

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Candel Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Candel Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
ABPRO P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABPRO P has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Candel Therapeutics and ABPRO P Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and ABPRO P

The main advantage of trading using opposite Candel Therapeutics and ABPRO P positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, ABPRO P can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABPRO P will offset losses from the drop in ABPRO P's long position.
The idea behind Candel Therapeutics and ABPRO P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk